Diamonds and Dogs
10/9/12
Edwards Lifesciences Corp. (EW)Edwards Lifesciences is giving its investors a heart attack today, down 22.87% at $84.99. The heart valve therapy company lost nearly $22.00 today after management lowered their company's forecast. Edwards said that preliminary sales for the quarter were $448 million, below the company's July expectation of $465 million to $485 million. The company blamed the miss on lower-than-expected sales of transcatheter heart valves, a replacement for faulty aortic valves that can be implanted through small incisions to avoid open-heart surgery. Today's drop in prices marks the largest intraday loss for Edwards since October of 2000. After today's large loss, some Edwards' investors might need the heart valve transplant.
BSD Medical Corp. (BSDM)
BSD Medical is bucking the trend today, up 72.88% at $2.04. The cancer treatment (heat therapy) company saw its shares pop after releasing positive news regarding its MicroThermX product. The MicroThermX Microwave Ablation System saw sales jump 391% in September 2012 versus September 2011. This is a dramatic increase in sales for MicroThermX products and representative of a continuing trend of accelerating revenue for this product. The world market potential for ablation products is estimated to exceed $2.3 billion. Needless to say, BSD could capture a good portion of that market with continued success of its MicroThermX product. With the market down significantly today (Dow down 110 points, S&P down 14, and Nasdaq down 47), BSD is one of the few stocks pushing toward its high.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.